Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-02 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
VIRX | Viracta Therapeutics | 7.88 | 0.00 | 0% |
You can purchase shares of Viracta Therapeutics (NASDAQ: VIRX) through any online brokerage.
Other companies in Viracta Therapeutics’s space includes: Neurocrine Biosciences (NASDAQ:NBIX), CureVac (NASDAQ:CVAC) and Amgen (NASDAQ:AMGN).
The latest price target for Viracta Therapeutics (NASDAQ: VIRX) was reported by Evercore ISI Group on 2021-03-25. The analyst firm set a price target for 45.00 expecting VIRX to rise to within 12 months (a possible 471.07% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Viracta Therapeutics (NASDAQ: VIRX) is $7.88 last updated Today at 8:00:02 PM.
There are no upcoming dividends for Viracta Therapeutics.
There is no upcoming split for Viracta Therapeutics.